BAL cell transcriptome predicts survival in IPF and can be used to gauge and model treatment effects interfering with the TGF-beta pathway

Conclusion: BAL cell transcriptome can be used to gauge treatment effects interfering with the TGF-beta pathway and indicates TGF-beta driven disease processes.

Source: European Respiratory Journal - November 19, 2018 Category: Respiratory Medicine Authors: Prasse, A., Carleo, A., Jaeger, B., Schupp, J., Rottoli, P., Wuyts, W., Kaminski, N. Tags: Idiopathic interstitial pneumonias Source Type: research